Skip to main content
Premium Trial:

Request an Annual Quote

Pat Brooks, Rebecca Galler, Keith Jones

Mission Bio has hired Pat Brooks as senior vice president of sales and sales operations, Rebecca Galler as senior vice president of marketing, and Keith Jones as senior vice president of product development.  

Brooks was previously vice president of global sales and development at Cellular Dynamics International. Prior to that, he held vice president positions at Ion Torrent, Pacific Biosciences, and Affymetrix. Brooks has a master of science and a bachelor of science degree from the University of Iowa.

Galler previously was previously involved in strategic marketing for Qventus and Castlight Health. In the past, she was head of corporate strategy at Sirna Therapeutics, director of private equity at Invesco Funds Group, and vice president of marketing at Preferred Global Health. She holds an MBA from Columbia University and a BA from Barnard College.

Jones used to be senior vice president of molecular assay research and development at Verinata Health, now part of Illumina. In the past, he was vice president of molecular genetics at Affymetrix. He holds a PhD in pharmacology from Stanford University School of Medicine and undergraduate degrees in chemistry and biological sciences from the University of California, Irvine.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.